| Name |
Consulting Fees/Honoraria |
Speaker's Bureau |
Research Grants |
Equity Interests/Stock/Stock Options |
Equity Interests |
Royalty Income |
Non-Royalty Payments |
Other Financial Benefit |
Salary |
Intellectual Property Rights |
Fellowship Support |
| Nancy M. Albert, R.N., Ph.D |
Medtronic |
|
|
|
|
|
|
|
|
|
|
| Inder S. Anand, M.D., Ph.D. |
Amgen Pharmaceuticals, Boston Scientific, Corventis, CVRx, Merck, Medtronic, N30, Paracor |
Novartis Pharmaceuticals |
CVRx, Novartis Pharmaceuticals, Paracor |
|
|
|
|
|
VA Medical Center |
|
|
| J. Malcolm O. Arnold, M.D. |
Abbott, Boehringer Ingelheim, GlaxoSmithKline, Merck-Frosst, Novartis, Pfizer |
|
|
|
|
|
|
|
|
|
|
| John P. Boehmer, M.D. |
Boston, Scientific, Medtronic, St. Jude |
|
Boston Scientific, CardioMEMS, Medtronic, Novartis, Paracor |
|
|
|
|
|
|
|
|
| John C. Burnett, M.D. |
Anexon, Nile Therapeutics, Otsuka |
|
Anexon, Bayer, BioRad, Merck, Nile Therapeutics, Trevena |
|
|
Anexon, Nile Therapeutics |
|
|
|
|
|
| John Chin, M.D. |
Gilead, Otsuka |
Boston Scientific, Eli Lilly, Gilead, Novartis |
|
|
|
|
|
|
|
|
|
| Jay N. Cohn, M.D. |
|
|
GlaxoSmithKline |
CPC, LLC |
HDT, Inc. |
MLHFQ, NitroMed |
|
|
|
|
|
| Sean P. Collins, M.D., MSc |
Abbott Point-of-Care, Astellas, Bayer, Corthera, The Medicines Company, Otsuka |
|
Abbott Point-of-Care, BRAHMS Diagnostics, National Institutes of Health/NHLBI |
|
|
|
|
|
|
|
|
| Justin A. Ezekowitz, MBBCh |
Amgen, Bristol-Myers Squibb, Pfizer |
|
Amgen, Bristol-Myers Squibb, Merck, Ortho-Biotech/Johnson & Johnson |
|
|
|
|
|
|
|
|
| Thomas Force, M.D. |
|
Merck Schering Plough/Merck |
|
|
|
|
|
GlaxoSmithKline |
|
|
|
| Bart Galle, Ph.D. |
disclosures: none |
|
|
|
|
|
|
|
|
|
|
| Michael M. Givertz, M.D. |
Cardioxyl |
|
Asahi Kasei |
|
|
|
|
|
|
|
|
| Sarah J. Goodlin, M.D. |
Servier |
|
Boston Scientific CARE, St. Jude Medical Foundation |
|
|
|
|
|
|
|
|
| Barry H. Greenberg, M.D. |
Biogen Idec, CardioMEMS, Corthera, Cytokinetics, GlaxoSmithKline, Otsuka, Paracor, St. Jude, Zensun |
Gilead, Merck, Novartis, sanofi-aventis |
|
|
|
|
|
|
|
|
|
| Ray E. Hershberger, M.D. |
disclosures: none |
|
|
|
|
|
|
|
|
|
|
| Steven R. Houser, Ph.D. |
disclosures: none |
|
|
|
|
|
|
|
|
|
|
| Jonathan G. Howlett, M.D. |
AstraZeneca, Merck, Novartis, Schering, Servier |
AstraZeneca, Merck, Novartis, Schering, Servier |
AstraZeneca, Medtronic, Merck, Novartis, Schering, Servier |
|
|
|
|
|
|
|
|
| Sharon A. Hunt, M.D. |
disclosures: none |
|
|
|
|
|
|
|
|
|
|
| Mariell Jessup, M.D. |
Medtronic |
Boston Scientific |
|
|
|
|
|
|
|
|
|
| Stuart D. Katz, M.D. |
Amgen, Dura Heart Terumo, Merck, Paracor |
|
|
|
|
|
|
|
|
|
|
| Marc Klapholz, M.D. |
GlaxoSmithKline, Medtronic, Paracor, St. Jude, Schering |
GlaxoSmithKline |
|
|
|
|
|
|
|
|
|
| Marvin W. Kronenberg, M.D. |
|
|
|
Cardiovascular Services of America |
|
|
|
|
|
|
|
| JoAnn Lindenfeld, M.D. |
Astellas, Boston Scientific, Forest, Medtronic, N30 |
|
Merck |
|
|
|
|
|
|
|
|
| Douglas L. Mann, M.D. |
ARMGO Pharmaceuticals, Medtronic, Miragen, Nile Therapeutics, PeriCor Therapeutics |
|
|
|
Miragen |
|
|
|
|
|
|
| Barry M. Massie, M.D. |
ARCA, Boehringer, Bristol-Myers Squibb, Corthera, Cytokinetics, Duke Clinical Research Institute, Merck, Nile Therapeutics, Novartis, sanofi-aventis, St. Jude, Takeda, Trevena |
Merck |
|
|
|
|
|
|
|
|
|
| Mandeep R. Mehra, M.D. |
Geron, Johnson & Johnson, Medtronic, Pericor, Solvay, St. Jude |
|
National Institutes of Health |
|
|
|
|
|
|
|
|
| Luisa Mestroni, M.D. |
|
M01 RR00051-1575 |
|
|
|
|
|
University of Colorado (employee) |
|
|
|
| Alan B. Miller, M.D. |
disclosures: none |
|
|
|
|
|
|
|
|
|
|
| Debra K. Moser, R.N., DNSc. |
disclosures: none |
|
|
|
|
|
|
|
|
|
|
| Mariann R. Piano, R.N., Ph.D. |
disclosures: none |
|
|
|
|
|
|
|
|
|
|
| Richard J. Rodeheffer, M.D. |
disclosures: none |
|
|
|
|
|
|
|
|
|
|
| Joseph G. Rogers, M.D. |
Forrest Pharmaceuticals, Thoratec |
Boston Scientific, Medtronic |
|
|
|
|
|
|
|
|
|
| Christine E. Seidman, M.D. |
|
|
HHMI & NIH |
|
|
|
|
|
|
|
|
| Randall C. Starling, M.D., MPH |
BioControl, Medtronic, Novartis |
|
Biotronik, Medtronic, Novartis, Thoratec |
CardioMEMS |
|
|
|
|
|
|
Medtronic |
| William G. Stevenson, M.D. |
disclosures: none |
|
|
|
|
|
|
|
|
|
|
| Wendy Gattis Stough, Pharm.D. |
ARCA Discovery, Inc., Gilead Sciences, Inc., GlaxoSmithKlline, Heart Failure Society of America, Medtronic, Otsuka, Scios |
|
|
|
|
|
|
|
|
|
|
| W.H. Wilson Tang, M.D. |
Medtronic, Merck & Company |
|
Abbott Laboratories |
|
|
|
|
|
|
|
|
| Matthew R.G. Taylor, M.D., Ph.D. |
|
Genzyme Therapeutics |
Muscular Dystrophy Association/March of Dimes/Genzyme Therapeutics |
|
|
|
|
|
|
|
|
| John R. Teerlink, M.D. |
Abbott Laboratories, BAS Medical/Corthera, Biogen Idec, Bristol-Myers Squibb, CardioDynamics, CardioMEMS, CoGeneSys, Cytokinetics, Geron, GlaxoSmithKline, Icon Medical Imaging, Indigo Pharma, Kowa Pharma, Luitpold Pharma, Merck, Momentum Research, Nile Therapeutics, Novartis, sanofi-aventis, Scios/Johnson & Johnson |
|
Abbott Laboratories, BAS Medical/Corthera, Bristol-Myers Squibb, Cytokinetics, GlaxoSmithKline, Merck, National Institutes of Health, Novartis, sanofi-aventis |
Cytokinetics |
|
|
|
|
|
|
|
| Jeffery A. Towbin, M.D. |
disclosure: none |
|
|
|
|
|
|
|
|
|
|
| Mary N. Walsh, M.D. |
ARCA, Boston Scientific, EMERGE, Medtronic, United Health Care |
|
|
|
|
|
|
|
|
|
|
| Clyde W. Yancy, M.D. |
disclosures: none |
|
|
|
|
|
|
|
|
|
|
| Cheryl Yano |
disclosures: none |
|
|
|
|
|
|
|
|
|
|
| Michael R. Zile, M.D. |
ABIM, BMS, CorAssist, CVRx, DC Devices, Gilead, Medtronic, Merck, N30, Novartis, OCD/J&J, sanofi-aventis, Up-To-Date |
|
BMS, Boston, Scientific, CVRx, Department of VA, Gilead, Medtronic, Merck, National Heart, Lung and Blood Institute, Novartis, OCD/J&J, Pfizer, sanofi-aventis |
|
|
|
|
|
Department of VA, MUSC, National Heart, Lung and Blood Institute |
MUSC, OCD/J&J |
|